| Execution period | 11 months |
|---|
BSE filing, NSE: OROSMITHS. Summary written from the filing by ALFA Finder's alert engine.
Orosil Smiths India Ltd: key numbers
- Share price
- ₹5.98
- Market cap
- ₹24.71 Cr
- Revenue (annual)
- ₹2.65 Cr
- Net profit (annual)
- ₹22.92 Cr
- P/E (TTM)
- 1.1×Sector 50.0×
- Promoter holding
- 61.26%+0.44% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orosil Smiths India Ltd
All →Orosil Smiths India Other Announcement
Orosil Smiths India Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Orosil Smiths India Promoter Buying
Promoter B K Narula HUF acquired 27,752 equity shares of Orosil Smiths India via open market. Post-acquisition stake increased to 16.07% from 16.01%.
- Promoter stake change
- +0.06%
Orosil Smiths India Other Announcement
Orosil Smiths India shareholders approved the appointment of M/s Prachi Bansal & Associates as secretarial auditor for a five-year term at the Annual General Meeting.
Orosil Smiths India Management Change
Orosil Smiths India Limited appointed Mr. Nikhil Jain as an Independent Director, as approved by shareholders at today's Annual General Meeting.
Orosil Smiths India Annual General Meeting
Orosil Smiths India Limited conducted its 32nd Annual General Meeting on September 25, 2026. Shareholders considered resolutions including financial statement adoption, director appointments, and increased investment limits.
Orosil Smiths India Promoter Buying
B K Narula HUF, a promoter, acquired 37,692 shares (0.09% stake) of Orosil Smiths India Limited via open market purchases. The promoter's stake increased to 16.01%.
- Promoter stake change
- +0.09%
Other capacity expansion announcements
All →Sat Kartar Life Capacity Expansion: ₹1 Cr Investment
Sat Kartar Life proposes a 25-bed Ayurveda hospital-cum-therapy centre in Lucknow at ₹1 Crore investment. Expected operational by February 2027 as part of its healthcare network expansion.
- Value
- ₹1.00 Cr
- Execution
- Expected operational by February 2027
- hospital beds
- 25 beds
Sukhjit Starch & Chemicals Capacity Expansion: ₹550 Cr Investment
Sukhjit Starch received MIDC confirmation for infrastructure supporting its 1200 TPD maize unit in Nashik. Project cost Rs. 550 Crore for capacity expansion.
- Value
- ₹550.0 Cr
- maize processing capacity
- 1200 TPD
Kiaasa Retail Capacity Expansion
Kiaasa Retail opened four new Exclusive Brand Outlets across Patiala, Bathinda, Dehradun, and Gola Gokarannath. The festive-season launch deepens its Tier-2 retail footprint.
- new Exclusive Brand Outlets (EBOs)
- 4 retail stores
Grand Continent Hotels Capacity Expansion
Grand Continent Hotels announces go-live of its 33rd property, a 56-room premium business hotel at Yelahanka, Bengaluru. The new property strengthens presence near Kempegowda International Airport.
- hotel rooms
- 56 rooms
Ambuja Cements Capacity Expansion: ₹14,500 Cr Investment
Ambuja Cements announces ~30 MTPA cement expansion with ₹14,500 Crore capex. Capacity will reach 155 MTPA by FY30 from current 113.5 MTPA.
- Value
- ₹14,500 Cr
- Execution
- through FY30
- new cement capacity (grinding + clinker)
- 30.0 MTPA
Krishna Institute of Medical Sciences Capacity Expansion
KIMS Saveera Hospital in Anantapur expanded from 250 to 500 beds, with new oncology and mother-and-child blocks inaugurated November 1, 2026. No monetary value disclosed.
- hospital beds
- 250.0 beds